The impact of COVID-19 pandemic on symptoms and functions in attention deficit hyperactivity disorder children in psychiatric out patient department at Ramathibodi hospital
Article Sidebar
Main Article Content
Abstract
Objective: To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on symptoms, functions in children with attention deficit hyperactivity disorder (ADHD) and the stress levels of their parents in Ramathibodi's psychiatric outpatient department.
Methods: This was a retrospective study. The data was collected from the Ramathibodi ADHD registry project at two periods which were before the second wave of COVID-19 pandemic and during the second wave of COVID-19 pandemic until the post pandemic phase predicted by the Ministry of Public Health. The population’s demographic data was summarized with percentage, mean and median. The symptoms, functions in children with ADHD and the stress levels of their parents from these two periods were compared by using Pair t-test and Wilcoxon signed rank test.
Results: Of the total 63 children, 73% were male. The mean age was 10.2±3.1 years. 70.5% of their parents lived together. 64.9% of the families earn more than 50,000 baths per month. During the second wave of COVID-19 pandemic until the post pandemic phase, the symptoms of hyperactivity and impulsivity and school performance were significant improved (p = 0.026, 0.046 respectively). Their parent's stress levels were not significantly difference (p = 0.986).
Conclusion: During the second wave of COVID-19 pandemic until the post pandemic phase, the symptoms of hyperactivity and impulsivity and school performance at Ramathibodi's psychiatric outpatient department were improved but the stress level of their parents were unaffected.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles submitted for consideration must not have been previously published or accepted for publication in any other journal, and must not be under review by any other journal.
References
Martin A, Volkmar FR, Lewis M, editors. Lewis's child and adolescent psychiatry: a comprehensive textbook. Lippincott Williams & Wilkins; 2007.
Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 2015;135: e994-1001.
Visanuyothin T, Pavasuthipaisit C, Wachiradilok P, Arunruang P, Buranasuksakul T. The prevalence of attention deficit/hyperactivity disorder in Thailand. J Ment Health Thai 2013;21:66-75.
DSM-5 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.
Çetin FH, Uçar HN, Türkoğlu S, Kahraman EM, Kuz M, Güleç A. Chronotypes and trauma reactions in children with ADHD in home confinement of COVID-19: full mediation effect of sleep problems. Chronobiol Int 2020;37:1214-22.
Centers for Disease Control and Prevention. COVID-19 situation report [Internet]. 2020 [cited 2021 Sep 30]. Available from: https://covid19.ddc.moph.go.th/.
Office of the Council of State. Regulation issued under section 9 of the Emergency Decree on Public Administration in Emergency Situation B.E. 2548 (2005) (No.1). Government Gazette Vol. 137, special section 69 d, dated 2020 Mar 25.
Office of the Council of State. Regulation issued under section 9 of the Emergency Decree on Public Administration in Emergency Situation B.E. 2548 (2005) (No.37). Government Gazette Vol. 138, special section 262 d, dated 2021 Oct 30.
Strategy and planning division of Office of the Permanent Secretary Ministry of Public Health. Endemic Approach to COVID-19 [Internet]. 2022 [cited 2022 Sep 30]. Available from: https://www.pyomoph.go.th/backoffice/files/42090.pdf
Office of the Council of State. Notification Re: Cancellation of the Declaration of an Emergency Situation in all areas of the Kingdom of Thailand. Government Gazette Vol. 139, special section 232 d, dated 2022 Sep 29.
Office of the Council of State. Regulation issued under section 9 of the Emergency Decree on Public Administration in Emergency Situation B.E. 2548 (2005) (No.5). Government Gazette Vol. 137, special section 102 d, dated 2020 May 1.
Panchal U, Salazar de Pablo G, Franco M, Moreno C, Parellada M, Arango C, et el. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review. Eur child Adolesc Psychiatry 2021;1-27.
Imran N, Aamer I, Sharif MI, Bodla ZH, Naveed S. Psychological burden of quarantine in children and adolescents: a rapid systematic review and proposed solutions. Pak J Med Sci 2020; 36:1106.
Sawyer MG, Arney FM, Baghurst PA, Clark JJ, Graetz BW, Kosky RJ, et el. The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry 2001; 35:806-14.
Gulliver A, Griffiths KM, Christensen H. Perceived barriers and facilitators to mental health help-seeking in young people: a systematic review. BMC Psychiatry 2010; 10:1-9.
Shah R, Raju VV, Sharma A, Grover S. Impact of COVID-19 and lockdown on children with ADHD and their families—an online survey and a continuity care model. J Neurosci Rural Pract 2021; 12:071-9.
Melegari MG, Giallonardo M, Sacco R, Marcucci L, Orecchio S, Bruni O. Identifying the impact of the confinement of COVID-19 on emotional-mood and behavioural dimensions in children and adolescents with attention deficit hyperactivity disorder (ADHD). Psychiatry Res 2021; 296: 113692.
Behrmann JT, Blaabjerg J, Jordansen J, Jensen de López KM. Systematic review: investigating the impact of COVID-19 on mental health outcomes of individuals with ADHD. J Atten Disord 2022;26:959-75.
Zhang J, Shuai L, Yu H, Wang Z, Qiu M, Lu L, et al. Acute stress, behavioural symptoms and mood states among school-age children with attention-deficit/hyperactive disorder during the COVID-19 outbreak. Asian J Psychiatr 2020; 51:102077.
Pityaratstian N, Booranasuksakul T, Juengsiragulwit D, Benyakorn S. ADHD screening properties of the Thai version of Swanson, Nolan, and Pelham IV scale (SNAP-IV) and strengths and difficulties questionnaire (SDQ). J Psychiatr Assoc Thailand 2014; 59:97-110.
Punyapas S, Pornnoppadol C, Boon-yasidhi V, Likhitkiatikhachorn P. Reliablity and validity of Weiss Functional Impairment Rating Scale (WFIRS)-Thai version in children and adolescents with attention deficit hyperactivity disorder. J Psychiatr Assoc Thailand 2015 ;60:111-26.
Wongpakaran N, Wongpakaran T. The Thai version of the PSS-10: an investigation of its psychometric properties. BioPsychoSocial Med 2010; 4:1-6.
Sibley MH, Ortiz M, Gaias LM, Reyes R, Joshi M, Alexander D, et al. Top problems of adolescents and young adults with ADHD during the COVID-19 pandemic. J Psychiatr Res 2021; 136: 190-7.
Masi A, Mendoza Diaz A, Tully L, Azim SI, Woolfenden S, Efron D, et al. Impact of the COVID-19 pandemic on the well-being of children with neurodevelopmental disabilities and their parents. J Paediatr Child Health 2021; 57:631-6.
Sciberras E, Patel P, Stokes MA, Coghill D, Middeldorp CM, Bellgrove MA, et al. Physical health, media use, and mental health in children and adolescents with ADHD during the COVID-19 pandemic in Australia. J Atten Disord 2022; 26:549-62.
Romero E, López-Romero L, Domínguez-Álvarez B, Villar P, Gómez-Fraguela JA. Testing the effects of COVID-19 confinement in Spanish children: the role of parents’ distress, emotional problems and specific parenting. Int J Environ Res Public Health 2020; 17:6975.
Roy A, Hechtman L, Arnold LE, Sibley MH, Molina BS, Swanson JM, et al. Childhood factors affecting persistence and desistence of attention-deficit/hyperactivity disorder symptoms in adulthood: results from the MTA. J Am Acad Child Adolesc Psychiatry 2016; 55:937-44.
Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 2004; 43:559-67.
Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001; 40:147-58.
Ter-Stepanian M, Grizenko N, Zappitelli M, Joober R. Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders. Can J Psychiatry 2010; 55:305-12.
Buitelaar JK, Van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1995; 34(8):1025-32.
Blouin B, Maddeaux C, Stanley Firestone J, van Stralen J. Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety. J Atten Disord 2010; 13:414-9.
Chronis-Tuscano A, Wang CH, Woods KE, Strickland J, Stein MA. Parent ADHD and evidence-based treatment for their children: review and directions for future research. J Abnorm Child Psychol 2017; 45:501-17.
Sibley MH, Ross JM, Gnagy EM, Dixon LJ, Conn B, Pelham WE. An intensive summer treatment program for ADHD reduces parent–adolescent conflict. J Psychopathol Behav Assess 2013; 35:10-9.
Jayanti O, Heide J. Attention-deficit/hyperactivity disorder severity, diagnosis, & later academic achievement in a national sample. Soc Sci Res 2017; 61:251-6.